Biocept

Biocept is a molecular oncology diagnostics company that specializes in the biomarker analysis of circulating tumor DNA and cells. Read more

Michael W. Nall's photo - President & CEO of Biocept

President & CEO

Michael W. Nall

CEO Approval Rating

78/100

Founded:

1997

Status:

PublicIndependent CompanyNASDAQBIOC

BIOCEPT TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Cynvenio is perceived as one of Biocept's biggest rivals. Cynvenio was founded in null, and is headquartered in Thousand Oaks, California. Like Biocept, Cynvenio also competes in the Biotechnology space. Cynvenio generates $38.8M less revenue vs. Biocept.

Circulogene is a top competitor of Biocept. Circulogene is a Private company that was founded in 2015 in Birmingham, Alabama. Like Biocept, Circulogene also works within the Biotechnology sector. Compared to Biocept, Circulogene has 51 fewer employees.

True Health Group LLC is Biocept's #3 rival. True Health Group LLC is headquartered in Frisco, Texas, and was founded in 2014. True Health Group LLC is in the Health Care Services industry. True Health Group LLC generates 34% the revenue of Biocept.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Genomic Health a competitor of Biocept?

Biocept Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$43.8M

Biocept's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 162.5M. Over the last four quarters, Biocept's revenue has grown by 1835.3%. Specifically, in Q1 2021's revenue was $17.8M; in Q4 2020, it was $18.5M; in Q3 2020, it was $6.6M; in Q2 2020, Biocept's revenue was $ < 1M.

Biocept Acquisitions

No recent acquisitions found related to Biocept

Biocept Funding History

Since Biocept was founded in 1997, it has participated in 9 rounds of funding. In total Biocept has raised $41.3M. Biocept's last funding round was on Dec 2019 for a total of $10.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Dec 2019
$10M
-
Private Placement
Aug 2017
$2.2M
Equity
Dec 2015
$1M
-
IPO
Feb 2014
$19M
-
Debt
Jan 2011
$1.2M
-

Since Biocept was founded in 1997, it has participated in 9 rounds of funding. In total Biocept has raised $41.3M. Biocept's last funding round was on Dec 2019 for a total of $10.0M

Biocept Investments

No recent investments found related to Biocept

Biocept News

June 2, 2021BioSpace

Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 02, 2021

Biocept, Inc., a leading provider of molecular diagnostic assays, products and services, announced th... See more »
May 14, 2021MarketScreener

Sales agreement (Form 8-K)

(marketscreener.com) Entry into a Material Definitive Agreement. On May 12, 2021, Biocept, Inc. enter... See more »
May 13, 2021Benzinga

Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept

Johnson & Johnson's (NYSE: JNJ) Vision segment has read more... See more »
May 13, 2021Proactive Investors

Biocept starts 2021 on a high with a profitable 1Q on revenue of $17.8M, driven by its coronavirus tests

The San Diego-based company also reported cash and equivalents as of March 31, 2021 of $14.2 million... See more »
May 12, 2021MarketScreener

Reports First Quarter 2021 Financial Results

(marketscreener.com) Revenues of $17.8 million were driven by RT-PCR COVID-19 testing Initiated full ... See more »
May 12, 2021Genomeweb

Biocept Q1 Revenues Up Dramatically as COVID-19 Testing Boost Lingers

The company accessioned 145,100 total samples in the quarter, 144,932 of which were billable samples,... See more »

Biocept Press Releases

November 17, 2020PR Newswire

Results from Study Using Biocept's Target Selector Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS

SAN DIEGO, Nov. 17, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider ... See more »
November 12, 2020PR Newswire

Biocept Reports Third Quarter 2020 Financial Results

SAN DIEGO, Nov. 12, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider ... See more »
October 29, 2020PR Newswire

Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received

SAN DIEGO, Oct. 29, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider ... See more »
September 9, 2020PR Newswire

Biocept to Present at the H.C. Wainwright Global Investment Virtual Conference on September 14

SAN DIEGO, Sept. 9, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider ... See more »
August 26, 2020Network Newswire

BIOC) Starts Presentation at The LD 500 - NetworkNewsWire

Biocept Inc. (NASDAQ: BIOC) is a leading commercial provider of molecular technologies designed to pr... See more »
June 30, 2020PR Newswire

Biocept Awarded Canadian Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells, from a Biological Fluid Sample such as Blood or Cerebrospinal Fluid

SAN DIEGO, June 30, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider ... See more »

Biocept Videos

March 15, 2018Biocept Vimeo Channel

"What is a Liquid Biopsy?" on VIMEO

We use a non-invasive blood test, known as a liquid biopsy, to help doctors and patients create more ... See more »
October 13, 2017Biocept Vimeo Channel

"Acknowledging Metastatic Breast Cancer Awareness Day | Biocept" on VIMEO

In honor of National Metastatic Breast Cancer Day, get the facts on a new tool for monitoring breast ... See more »
October 6, 2017Biocept Vimeo Channel

"Empower TC, Tech-Only Liquid Biopsy Service | Biocept" on VIMEO

We're proud to introduce the first tech only liquid biopsy service!Facebook : https://www.facebook.co... See more »
September 29, 2017Biocept Vimeo Channel

"Prostate Cancer Awareness Month | Biocept" on VIMEO

We're proud to support Prostate Cancer Awareness Month.Facebook : https://www.facebook.com/bioceptLin... See more »
September 6, 2017Biocept Vimeo Channel

"Biocept Launches NRAS Liquid Biopsy Test | Biocept" on VIMEO

We are proud and excited to announce the launch of our liquid biopsy for NRAS mutations!Facebook : ht... See more »
August 17, 2017Biocept Vimeo Channel

"New PR Test to Help Understand Breast Cancer | Biocept" on VIMEO

We offer a new way to help doctors understand their patients' breast cancer.Facebook : https://www.fa... See more »
August 17, 2017Biocept Vimeo Channel

"Tissue AND Liquid Biopsy | Biocept" on VIMEO

It's all about the AND. Discover how tissue AND liquid biopsies can help provide needed information i... See more »

Social Media

Biocept Headquarters

9955 Mesa Rim Road

San Diego, California92121

858-320-8200

Driving Directions »

Trending Companies

Biocept Summary

ABOUT

Overview

Biocept is a molecular oncology diagnostics company that specializes in the biomarker analysis of circulating tumor DNA and cells. Biocept was founded in 1997. Biocept's headquarters is located in San Diego, California, USA 92121. It has raised 41.3M ...

CEO

Biocept's President & CEO, Michael W. Nall, currently has an approval rating of 78%. Biocept's primary competitors are Cynvenio, Circulogene & True Health Group LLC.

Frequently Asked Questions about Biocept

  1. When was Biocept founded?

    Biocept was founded in 1997
  2. Who is Biocept's CEO?

    Biocept's CEO is Michael W. Nall
  3. How much revenue does Biocept generate?

    Biocept generates $43.8M in revenue
  4. How much funding does Biocept have?

    Biocept has historically raised $41.3M in funding
  1. Where is Biocept's headquarters?

    Biocept's headquarters is in San Diego California, USA
  2. How many employees does Biocept have?

    Biocept has 87 employees
  3. What sector does Biocept operate in?

    Biocept is in Biotechnology
  4. Who are Biocept's competitors?

    Biocept's top competitors are Cynvenio, Circulogene, True Health Group LLC